• Synthomer published its Annual Report 2025, highlighting continued execution of strategy to simplify portfolio and shift further toward speciality products.
• Divestment of William Blythe completed in May 2025, with four additional divestment processes under way to accelerate deleveraging.
• Bank facilities refinanced on April 30, 2026, extending maturities to February 2029 with revised covenants.
• Cost reduction program expanded, including removal of around 250 roles, with further annual run-rate savings of GBP 20-25 million targeted into 2026.
• Innovation focus continued, with new and protected products at 23% of sales volume in 2025 and shift planned in 2026 to track innovation via gross margin vitality.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Synthomer plc published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the information contained therein.